Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Melanoma × Exercise × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 107 Breast Neoplasms 64 Neoplasms 44 Prostatic Neoplasms 18 Obesity 14 Fatigue 13 Lung Neoplasms 11 Colorectal Neoplasms 11 Polycystic Ovary Syndrome 9 Colonic Neoplasms 8 Head and Neck Neoplasms 7 Weight Loss 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Ovarian Neoplasms 6 Rectal Neoplasms 5 Inflammation 5 Overweight 4 Multiple Myeloma 4 Lymphedema 4 Leukemia, Myeloid, Acute 4 Leukemia 4 Cognitive Dysfunction 4 Brain Neoplasms 4 Multiple Endocrine Neoplasia Type 1 3 Lymphoma, Follicular 3 Lymphoma 3 Insulin Resistance 3 Depression 3 Cardiotoxicity 3 Carcinoma, Non-Small-Cell Lung 3

Interventions

Ipilimumab 100 pembrolizumab 84 aldesleukin 81 Nivolumab 79 Interleukin-2 50 Cyclophosphamide 50 Dacarbazine 47 Vemurafenib 35 trametinib 34 incomplete Freund's adjuvant 33 fludarabine phosphate 32 Temozolomide 32 sargramostim 29 dabrafenib 27 Bevacizumab 23 fludarabine 22 Paclitaxel 21 montanide ISA 51 20 MART-1 Antigen 20 Cisplatin 19 Carboplatin 18 Sorafenib 17 Interferon-alpha 17 Granulocyte-Macrophage Colony-Stimulating Factor 17 atezolizumab 15 Radiosurgery 15 Introns 15 Blood Specimen Collection 15 cobimetinib 14 Filgrastim 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06694571 2025-10-14

STARS

University of Utah

Phase NA Completed

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡